FDA Inspection
Karyopharm Therapeutics Inc.Karyopharm Therapeutics Inc. – FDA Inspection, Feb 8, 2017
Record Details
This FDA Inspection record concerns Karyopharm Therapeutics Inc., with an inspection on February 8, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Cynthia F. Kleppinger (Issuing Officer)
- Darin S. Wiegers (Issuing Officer)
- Rachel M. Skeete (Issuing Officer)
View Company Profile
ID · 8eb40be4-18ba-41d3-b5de-ba4c4b35c3b5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009153
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Karyopharm Therapeutics Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 15, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 28, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Karyopharm Therapeutics Inc.
- FDA Inspection 1202243 - 2023-03-15
- FDA Inspection 1122926 - 2020-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.